Cargando…
The utility of biomarkers in hepatocellular carcinoma: review of urine-based (1)H-NMR studies – what the clinician needs to know
Hepatocellular carcinoma (HCC) is the fifth most common malignancy, the third most common cause of cancer death, and the most common primary liver cancer. Overall, there is a need for more reliable biomarkers for HCC, as those currently available lack sensitivity and specificity. For example, the cu...
Autores principales: | Cartlidge, Caroline R, U, M R Abellona, Alkhatib, Alzhraa M A, Taylor-Robinson, Simon D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708191/ https://www.ncbi.nlm.nih.gov/pubmed/29225478 http://dx.doi.org/10.2147/IJGM.S150312 |
Ejemplares similares
-
Radioembolization for hepatocellular carcinoma: what clinicians need to know
por: Choi, Jin Woo, et al.
Publicado: (2022) -
Chyluria: what does the clinician need to know?
por: Stainer, Victoria, et al.
Publicado: (2020) -
Artificial Intelligence for Anesthesia: What the Practicing Clinician Needs to Know
por: Mathis, Michael R., et al.
Publicado: (2018) -
Gene Expression Profiles – What the Clinician Needs to Know
por: Gall-Troselj, Koraljka
Publicado: (2005) -
Children in Coronaviruses’ Wonderland: What Clinicians Need to Know
por: Lassandro, Giuseppe, et al.
Publicado: (2020)